Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMHNR36)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE; 2-[(cyclohexylcarbamoyl)amino]acetic acid; CHEMBL66380; 33557-91-4; 2-(3-cyclohexylureido)acetic acid; Glycine, N-[(cyclohexylamino)carbonyl]-; 4-(3-CYCLOHEXYLURIEDO)-ETHANOIC ACID; NC3; 2-(cyclohexylcarbamoylamino)acetic acid; 1zd2; N-(cyclohexylcarbamoyl)glycine; AC1Q760W; AC1N5Q71; CTK1B1676; DTXSID90399930; MolPort-002-472-569; HMS3604L13; (3-Cyclohexyl-ureido)-acetic acid; ZINC6691828; BDBM50143914; AKOS000132958; NE25644; MCULE-8014113453; DB08256; [(cyclohexylcarbamoyl)amino]acetic acid
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||